Current Investments
We invest in innovative medical technology companies regardless of stage of development, ranging from pre-prototype to significantly revenue generating. Our investments range from under €1million to €10million per company.
| Company | Type | Stage* |
|---|---|---|
| 2010 Perfect Vision | Ophthalmology |
Commercial Development |
| Advanced Cardiac Therapeutics | Cardiovascular |
Prototype |
| BoneSupport | Orthopedic |
Clinical Trials |
| Cellnovo | Diabetes |
Clinical Trials |
| DySIS Medical | Imaging |
Pre-prototype |
| EOS Imaging | Medical Devices |
Series C |
| Estech | Cardiovascular |
Commercial Growth |
| Quanta Fluid Solutions | Renal dialysis |
Prototype |
| Reverse Medical | Cardiovascular |
Pre-prototype |
| SuperSonic Imagine | Imaging |
Pre-prototype |
| Symetis | Cardiovascular |
Clinical Trials |
| Upfront Chromatography | Biochemistry |
Commercial Development |
* Stage of company at our first investment
2010 Perfect Vision
20/10 Perfect Vision® has developed a highly innovative surgical laser system offering a variety of novel applications.
- Type:
- Ophthalmology
- Stage:
- Commercial Development
- Country:
- Germany
Advanced Cardiac Therapeutics
ACT is developing an innovative irrigated cardiac catheter ablation system that will enable tissue temperature measurement during the application of radiofrequency energy. This permits Electro-Physiologists greater control in their lesion creation and has the potential to improve patient outcomes.
- Type:
- Cardiovascular
- Stage:
- Prototype
- Country:
- USA
BoneSupport
BoneSupport develops innovative products addressing various spine conditions.
- Type:
- Orthopedic
- Stage:
- Clinical Trials
- Country:
- Sweden
Cellnovo
Cellnovo is a UK company developing and manufacturing an innovative mobile diabetes management system.
- Type:
- Diabetes
- Stage:
- Clinical Trials
- Country:
- UK
DySIS Medical
DySIS Medical has developed an innovative device for the non-invasive, early and accurate detection of cervical cancer.
- Type:
- Imaging
- Stage:
- Pre-prototype
- Country:
- UK
EOS Imaging
EOS Imaging has developed the EOS device, a novel 3D digital x-ray imaging system.
- Type:
- Medical Devices
- Stage:
- Series C
- Country:
- France
Estech
Estech has developed an innovative range of products for minimally invasive cardiac surgery procedures.
- Type:
- Cardiovascular
- Stage:
- Commercial Growth
- Country:
- USA
Quanta Fluid Solutions
Quanta is developing SelfCare+, the world’s first true self-care haemodialysis machine using a revolutionary design to give simplicity, reliability, portability and high treatment quality for renal patients.
- Type:
- Renal dialysis
- Stage:
- Prototype
- Country:
- UK
Reverse Medical
Reverse Medical develops novel systems for use in carotid artery stenting and neurovascular applications.
- Type:
- Cardiovascular
- Stage:
- Pre-prototype
- Country:
- USA
SuperSonic Imagine
SuperSonic Imagine has developed an ultrasound system with an innovative medical platform that can measure and visualize tissue elasticity.
- Type:
- Imaging
- Stage:
- Pre-prototype
- Country:
- France
Symetis
Symetis is a Swiss company developing innovative, minimally-invasive heart valve replacement solutions for patients suffering from heart valve diseases.
- Type:
- Cardiovascular
- Stage:
- Clinical Trials
- Country:
- Switzerland
Upfront Chromatography
Upfront has developed a unique chromatographic process based on Expanded Bed Adsorption (EBA).
- Type:
- Biochemistry
- Stage:
- Commercial Development
- Country:
- Denmark